Nalmefene: first drug for reducing alcohol consumption

descriptionPublicationkeyboard_double_arrow_right Article 19 Jun 2014 English Publisher:WileyJournal:Prescriber, volume 25, pages 12-14 (issn: 0959-6682, eissn: 1931-2253,

Copyright policy )

Authors: Steve Chaplin; Jonathan Chick;

doi: 10.1002/psb.1218

Nalmefene: first drug for reducing alcohol consumption

- Summary
- Metrics

Abstract

Abstract Nalmefene (Selincro) is the first drug approved for the reduction of alcohol consumption. In our New products review, Steve Chaplin presents the data relating to its efficacy and adverse events, and Professor Jonathan Chick discusses its place in therapy.

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average